We mainly develop applications of our own patented DIANA technology, which was invented by the company's CEO and scientific director Václav Navrátil during his work at the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences. However, our portfolio is significantly broader and we aim for global markets with our products. In addition to the development of new drugs and diagnostic methods for the detection of new biomarkers, we focus, for example, on the development of monoclonal antibodies for diagnostics as well as therapies. Here, you can find everything we do.
We have a team of top scientists with unique expertise in molecular biology, biochemistry, organic and medicinal chemistry, pharmacology and laboratory automation. Our goal is to become a multinational biotechnology company that will develop its own original drugs. For this purpose, we acquired significant private investment capital. We are based in Vestec near Prague.
We are an innovative biotechnology company, which was established as a spin-off from the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. Nice to meet you!